[Functional upper abdominal pain in Campylobacter-associated gastritis: does the patient profit from bismuth therapy?].
Koop
H
H
Zentrum für Innere Medizin, Phillips-Universität, Marburg.
D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D002169:Campylobacter Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004415:Dyspepsia / Q000188:drug therapy*; D005756:Gastritis / Q000188:drug therapy*; D006801:Humans; D009942:Organometallic Compounds / Q000008:administration & dosage*
D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; C002791:bismuth tripotassium dicitrate
Funktionelle Oberbauchschmerzen bei Campylobacter-assoziierter Gastritis: Profitiert der Patient von einer Wismut-Therapie?